DEKON AGR (02419) intends to conduct a share buyback in the market.
Dekang Agriculture and Animal Husbandry (02419) issued an announcement, resolving to exercise based on the company's shareholders' decision on April 22, 2025, depending on market conditions...
DEKON AGR (02419) issued an announcement that the board will exercise the power under the general authorization (share repurchase authorization) granted by the resolution passed by the shareholders at the Company's 2024 Annual General Meeting held on April 22, 2025, to repurchase the Company's H shares, depending on market conditions.
The board has decided to exercise the share repurchase authorization, with the intention to repurchase shares with a total value not exceeding HK$500 million. The H shares repurchased this time will mainly be used for employee share plans, equity incentives, or other situations permitted by laws, regulations, and administrative regulations. The board will repurchase H shares on the open market based on market conditions (recommended share repurchase).
According to the share repurchase authorization, the number of H shares to be repurchased shall not exceed 10% of the total number of H shares issued as of the date of the Special Resolution passed at the Annual General Meeting of Shareholders (excluding any repurchased but not yet cancelled H shares), i.e., 12,806,400 H shares.
Related Articles

Vitalhi Holdings: Revenue of 3.08 billion yuan in the first half of 2025, with more than 90% coming from AI medical services.

New Stock News: Leo Group Co., Ltd. (002131.SZ) submitted an application to the Hong Kong Stock Exchange for the A+H listing of its digital marketing and intelligent pump and system business.

CARDIOFLOW-B(02160) has entered into a merger agreement with its subsidiary and minimally invasive arrhythmia management.
Vitalhi Holdings: Revenue of 3.08 billion yuan in the first half of 2025, with more than 90% coming from AI medical services.

New Stock News: Leo Group Co., Ltd. (002131.SZ) submitted an application to the Hong Kong Stock Exchange for the A+H listing of its digital marketing and intelligent pump and system business.

CARDIOFLOW-B(02160) has entered into a merger agreement with its subsidiary and minimally invasive arrhythmia management.

RECOMMEND

Chery Automobile’s Hong Kong Listing: Threefold Challenge of Electrification, Premiumization, and Profitability
29/09/2025

Up to 100%! Trump Announces Fresh Tariffs on Heavy Trucks, Furniture, and Pharmaceuticals
29/09/2025

Hong Kong Unveils Fixed Income and Currency Market Roadmap to Establish Global Hub
29/09/2025